WithdrawnNCT05299398
Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone
Medication studyAges 18–45Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: April 17, 2025
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Verinder Sharma
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Canada
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT05299398
- Official title
Show the full official title
Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone
Recruitment & locations
WithdrawnLondon
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Verinder Sharma.
Does this study involve medication?
Yes. The study involves medication, including Trazodone and Placebo.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
